Skip to content

HAEMONETICS CORP

HAE · XNYS

CIK 313143fmd_0BKM5ZZM8Y46Z1YQXRSAQPZH7TManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Mar 30, 2008 to Sep 26, 2026, 71 periods

Latest annual · FY2026

Millions
Total revenues
1,334
Gross profit
788
Operating income
157
Net income
97
Free cash flow
260

Latest quarter · Q2 FY2027

Millions
Total revenues
358
Gross profit
221
Operating income
75
Net income
46
Free cash flow
113

Daily close · HAEIEX trades only

Nov 13, 2025 to Nov 11, 2026 · 250 sessions

120.67 USD

406080100120140Nov 13, 2025May 14, 2026Nov 11, 2026Vol

Built from trades executed at IEX only, one exchange with a small share of US volume. This is not the consolidated tape. The close is the last IEX trade of the session, not the official closing price. Earlier sessions are divided by the later split ratios the API confirmed against IEX prices; dividends are not adjusted. Switch to As traded for the prices as they printed. End of day, not real time: a session is published the day after it trades.

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms

Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2023 to FY2026
+4.5%
Revenue, 5 yearsFY2021 to FY2026
+8.9%
Net income, 5 yearsFY2021 to FY2026
+4.1%

HAEMONETICS CORP (HAE) financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2026FY2025ChangeSource
Revenue$1.3 billion$1.4 billion-2%10-K 2026-05-20 · proof
Gross profit$787.6 million$749 million+5.2%10-K 2026-05-20 · proof
Operating income$156.7 million$221.8 million-29.3%10-K 2026-05-20 · proof
Net income$97.3 million$167.7 million-42%10-K 2026-05-20 · proof
Cash from operating activities$293.2 million$181.7 million+61.4%10-K 2026-05-20 · proof
Free cash flow$260.4 million$142.4 million+82.8%10-K 2026-05-20 · proof
Total assets$2.4 billion$2.5 billion-2.2%10-K 2026-05-20 · proof
Total liabilities$1.6 billion$1.6 billion-1.9%10-K 2026-05-20 · proof
Cash and cash equivalents$245.4 million$306.8 million-20%10-K 2026-05-20 · proof
Total debt$1.2 billion$1.2 billion0%10-K 2026-05-20 · proof
What was HAEMONETICS CORP (HAE)'s revenue in fiscal 2026?
HAEMONETICS CORP (HAE) reported revenue of $1.3 billion for fiscal 2026 (the year ended Mar 28, 2026), against $1.4 billion the year before (-2%). Source: the 10-K filed with the SEC on May 20, 2026. SEC
What was HAEMONETICS CORP (HAE)'s gross profit in fiscal 2026?
HAEMONETICS CORP (HAE) reported gross profit of $787.6 million for fiscal 2026 (the year ended Mar 28, 2026), against $749 million the year before (+5.2%). Source: the 10-K filed with the SEC on May 20, 2026. SEC
What was HAEMONETICS CORP (HAE)'s operating income in fiscal 2026?
HAEMONETICS CORP (HAE) reported operating income of $156.7 million for fiscal 2026 (the year ended Mar 28, 2026), against $221.8 million the year before (-29.3%). Source: the 10-K filed with the SEC on May 20, 2026. SEC
What was HAEMONETICS CORP (HAE)'s net income in fiscal 2026?
HAEMONETICS CORP (HAE) reported net income of $97.3 million for fiscal 2026 (the year ended Mar 28, 2026), against $167.7 million the year before (-42%). Source: the 10-K filed with the SEC on May 20, 2026. SEC
What was HAEMONETICS CORP (HAE)'s cash from operating activities in fiscal 2026?
HAEMONETICS CORP (HAE) reported cash from operating activities of $293.2 million for fiscal 2026 (the year ended Mar 28, 2026), against $181.7 million the year before (+61.4%). Source: the 10-K filed with the SEC on May 20, 2026. SEC
What was HAEMONETICS CORP (HAE)'s free cash flow in fiscal 2026?
HAEMONETICS CORP (HAE) reported free cash flow of $260.4 million for fiscal 2026 (the year ended Mar 28, 2026), against $142.4 million the year before (+82.8%). Source: the 10-K filed with the SEC on May 20, 2026. SEC
What are HAEMONETICS CORP (HAE)'s total assets?
As of Mar 28, 2026, HAEMONETICS CORP (HAE) reported total assets of $2.4 billion, against $2.5 billion a year earlier (-2.2%). Source: the 10-K filed with the SEC on May 20, 2026. SEC
What are HAEMONETICS CORP (HAE)'s total liabilities?
As of Mar 28, 2026, HAEMONETICS CORP (HAE) reported total liabilities of $1.6 billion, against $1.6 billion a year earlier (-1.9%). Source: the 10-K filed with the SEC on May 20, 2026. SEC
What are HAEMONETICS CORP (HAE)'s cash and cash equivalents?
As of Mar 28, 2026, HAEMONETICS CORP (HAE) reported cash and cash equivalents of $245.4 million, against $306.8 million a year earlier (-20%). Source: the 10-K filed with the SEC on May 20, 2026. SEC
What is HAEMONETICS CORP (HAE)'s total debt?
As of Mar 28, 2026, HAEMONETICS CORP (HAE) reported total debt of $1.2 billion, against $1.2 billion a year earlier (0%). Source: the 10-K filed with the SEC on May 20, 2026. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:HAE&period_type=annual&limit=5"

Information only, not investment advice.